Greater international and gender diversity among UK pharma execs

12 April 2017

In a finding that might add weight to industry calls for continued free movement of vital talent post-Brexit, a study has shown that country managers and European heads in UK pharma are far more internationally diverse than their French and German counterparts.

New research published by Heidrick & Struggles (Nasdaq: HSII), a leading provider of executive search, leadership consulting and culture shaping worldwide, shows that, in stark contrast to France, where only 7% of these execs have international backgrounds, almost three-quarters (70%) of those in the UK come from outside the UK. In Germany, a third of senior roles are held by non-German nationals.

"In general, hiring trends remain too conservative"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK